Abstract:Background & aims: The expression of HBsAg from integrated HBV DNA limits the achievement of functional cure for chronic hepatitis B. Thus, characterising the unique expression and secretion of HBsAg derived from integrated HBV DNA is of clinical significance. Methods: A total of 563 treatment-naive patients and 62 functionally cured patients were enrolled, and HBsAg and HBcAg immunohistochemistry of their liver biopsy tissues was conducted followed by semi-quantitative analysis. Then, based on stratified analysis of HBeAg-positive and -negative patients, long-read RNA sequencing analysis, as well as an in vitro HBV integration model, we explored the HBsAg secretion characteristics of integrated HBV DNA and underlying mechanisms. Results: In contrast to the significantly lower serum HBsAg levels, no significant decrease of intrahepatic HBsAg protein was observed in HBeAg-negative patients, as compared with HBeAg-positive patients. The results of long-read RNA sequencing of liver tissues from patients with chronic HBV infection and in vitro studies using integrated HBV DNA mimicking dslDNA plasmid revealed that, the lower HBsAg secretion efficiency seen in HBeAg-negative patients might be attributed to an increased proportion of preS1 mRNA derived from integrated HBV DNA instead of covalently closed circular DNA. The latter resulted in an increased L-HBsAg proportion and impaired HBsAg secretion. Enhancer 1 (EnhI) in integrated HBV DNA could retarget preS1 (SP1) and preS2 (SP2) promoters to disrupt their transcriptional activity balance. Conclusions: The secretion of HBsAg originating from integrated HBV DNA was impaired. Mechanistically, functional deficiency of core promoter leads to retargeting of EnhI and thus uneven activation of the SP1 over the SP2 promoter, resulting in an increase in the proportion of L-HBsAg. Impact and implications: Integrated hepatitis B virus (HBV) DNA can serve as an important reservoir for HBV surface antigen (HBsAg) expression, and this limits the achievement of a functional cure. This study revealed that secretion efficiency is lower for HBsAg derived from integrated HBV DNA than HBsAg derived from covalently closed circular DNA, as determined by the unique sequence features of integrated HBV DNA. This study can broaden our understanding of the role of HBV integration and shed new light on antiviral strategies to facilitate a functional cure. We believe our results are of great general interest to a broad audience, including patients and patient organisations, the medical community, academia, the life science industry and the public.

Functional Characterization of Hepatitis B Virus Core Promoter Mutants Revealed Transcriptional Interference among Co-Terminal Viral Mrnas.

Inhibition of Hepatitis B Virus Gene Expression and Replication by Hepatocyte Nuclear Factor 6

Mutations in Precore and Core Promoter Region of HBV in Patients with Hepatic Failure.

In vitro resistance to interferon-alpha of hepatitis B virus with basic core promoter double mutation.

HBV C Promoter Sp1 Binding Sequence Functionally Substitutes for the Yeast ARS1 ABF1 Binding Site

Regulatory Effect of HBV Integrated Fragment on PCNA Promoter.

Cloning and Implication of Eukaryotic Expression Vectors Containing Hepatitis B Virus Genomes with Partial Deletion in the Core Promoter

Quasispecies and Variations of Hepatitis B Virus:Core Promotor Region As an Example

Primary Study on Core Promoter Deletion Mutation in Hepatitis B Virus

Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C.

Effect of Multiple Mutations in the Core Promoter and Pre‐core/core Region of Hepatitis B Virus Genome on the Response to Interferon in E Antigen‐positive Chronic Hepatitis B

A Study on the Heterogeneity of Core Promoter Region in Hepatitis B Virus DNA

Quasispecies Groups in the Core Promoter Region of Hepatitis B Virus.

The Effect of Mutation of Hepatitis B Virus Core Protein Dimer Interface Domain Related to Nucleocapsid Formation on HBV Replication

[Effects of Partial Deletion in the Core Promoter of Hepatitis B Virus Genome on Viral Antigen Expressions].

The A1762T/G1764A Mutations Enhance HBV Replication by Alternating Viral Transcriptome.

HBV core protein allosteric modulators differentially alter cccDNA biosynthesis from de novo infection and intracellular amplification pathways

Hepatitis B virus enhancer 1 activates preS1 and preS2 promoters of integrated HBV DNA impairing HBsAg secretion

Cmv Promoter and the Mouse Albumin Promoter and Enhancer Triggered the Elevation of Hepatitis B Virus Envelope Polypeptides

Inhibition of the HCV Core Protein on the Immune Response to HBV Surface Antigen and on HBV Gene Expression and Replication in Vivo.

Amino Acid Residues at Core Protein Dimer-Dimer Interface Modulate Multiple Steps of Hepatitis B Virus Replication and HBeAg Biogenesis